PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2147370
PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2147370
This Marketstrat® Focus Report assesses the US ultrasound market from 2024A through 2035E, drawing on the Global Ultrasound Horizon model and developments through September 2026, with a Canada sidebar. Our view is that utilization economics, not device specifications alone, will decide the next phase: providers need more usable examinations per staffed session, and vendors need to keep accounts across hardware generations.
The core ecosystem combines systems, service and aftermarket, and core AI recurring revenue across five hardware segments. Shipments outpace systems revenue as lower-priced formats broaden the installed base. Core AI recurring revenue grows fastest, yet hardware still supplies most incremental revenue through 2035.
GE HealthCare and Philips are assessed as premium, workflow-oriented incumbents, FUJIFILM Sonosite as a bedside and procedural specialist, and Mindray as a price-performance challenger. Butterfly Network and Clarius represent handheld platforms. AI specialists such as Us2.ai and Koios Medical are reviewed by route to scale, and recent clearances from ThinkSono, RadNet/DeepHealth and ROPCA are treated as evidence milestones.
Market model: Revenue, shipments and installed base by hardware segment, 2024A–2035E.
Frameworks: The US Growth-Engine Matrix and an ARC-Index read across seven AI capabilities, plus the AI value-pool bridge.
Policy and trade: CY2027 fee schedule and OPPS proposals, service-specific coding, and Section 301 and 232 interaction.
Structure views and outlook: Purchase-model, end-market, application and operating-model allocations, signals to watch over 12–24 months, and implications by stakeholder.
The report keeps AI value pools, purchasing models and end markets as reconciled views of one revenue base rather than separate markets to add together. It separates company-reported clearances from measured adoption and turns policy proposals into commercial tests.